Aktiespot

Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aksje

TRABI.BO

Stengt
₹3.0900-0.0100 (-0.32%)
Laster graf...
TRANSGENE BIOTEK LTD. logo

TRANSGENE BIOTEK LTD.

Åpning3.0200
Høy3.1800
Lav3.0200
Volum31.48k
P/EN/A
Markedsverdi234.13M
52-ukers høy5.2600
52-ukers lav1.8300
Gj.sn. volum52.65k
UtbytteN/A
BetaN/A
EPS-0.2500

Om Transgene Biotek Limited (TRANSGENE BIOTEK LTD.) aksje

Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India. It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption. The company was incorporated in 1990 and is based in Sangareddy, India.

Selskapsinformasjon

Børs: BSE (BSE)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Plot No. 69 & 70
502325 Sangareddy, India
Telefon: + 91 40 6558 9499

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: